Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

US regions reporting controlled Rx drugs as greatest drug threat 2014-2017

This statistic shows (OCDETF) regions in the U.S. reporting controlled prescription drugs (CPDs) as greatest drug threat in the U.S. from 2014 to 2017. In 2014, seven percent of respondents from agencies in the Pacific region reported CPDs as the greatest drug threat for this region.

U.S. regions reporting controlled prescription drugs (CPDs) as greatest drug threat from 2014 to 2017*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

October 2017

Region

United States

Survey time period

2014 to 2017

Number of respondents

5,155 respondents

Special properties

law enforcement agencies

Supplementary notes

* Regions as defined by the OCDEFT (Organized Crime Drug Enforcement Task Force).
CPDs: Not all prescription drugs are listed as controlled prescription drugs in the Controlled Substances Act. However, many prescription drugs are listed in Schedules I through V of the Controlled Substances Act because of their high potential for abuse or addiction. Schedule I through V prescription drugs primarily are narcotic pain relievers and central nervous system depressants and stimulants. A complete list of controlled prescription drugs, by schedule, is available on the DEA Office of Diversion Control Internet site.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Opioid use in the U.S."

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.